Study | Reason for exclusion |
---|---|
Caluwé 2016 | Wrong intervention: rivaroxaban versus rivaroxaban plus vitamin K2 versus vitamin K antagonist |
Eriksson 2003a | Pharmacokinetic/pharmacodynamic RCT of ximelagatran and melagatran |
Koretsune 2015 | Pharmacokinetic/pharmacodynamic RCT of 3 treatment regimens of edoxaban |
Murray 2004 | Pharmacokinetic/pharmacodynamic cross‐over RCT of 3 treatment regimens of argatroban |
RCT ‐ randomised controlled trial